Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank25
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Latest
-24.10%
↑ 87% vs avg
Percentile
P25
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-190.40%
Historical baseline
PeriodValue
2024-24.10%
2023-5.51%
2022-17.41%
2021-905.00%
20200.00%